Search clinical trials for: ALXN1720
Total 63 results
-
Novartis PharmaceuticalsCompletedSecondary Progressive Multiple SclerosisChina, Germany, United States, Romania, Italy, Austria, Belgium, Czechia, Spain, Australia, Canada, France, Israel, Switzerland, Bulgaria, Hungary, Netherlands, United Kingdom, Estonia, Latvia, Lithuania, Russian Federation, Turkey, J... and more
-
BioCryst PharmaceuticalsTerminatedBCX9930 for Treatment of PNH in Subjects With Inadequate Response to C5 Inhibitor Therapy (REDEEM-1)Paroxysmal Nocturnal Hemoglobinuria (PNH)United Kingdom, Hungary, France, Italy, Spain
-
Regeneron PharmaceuticalsTerminatedParoxysmal Nocturnal HemoglobinuriaUnited States
-
Alexion Pharmaceuticals, Inc.Completed
-
AlexionPPD; ERT: Clinical Trial Technology SolutionsCompleted
-
AlexionCompleted
-
AlexionNo longer available
-
Alexion Pharmaceuticals, Inc.CompletedWilson DiseaseUnited States, Spain, United Kingdom, New Zealand, Denmark, Russian Federation, Canada, Singapore
-
AlexionCompleted
-
AlexionCompleted
-
Alexion Pharmaceuticals, Inc.TerminatedWilson DiseaseUnited States, Spain, Taiwan, France, Czechia, Hungary, Turkey, United Kingdom, Austria, Germany, Israel, Serbia, Australia, Japan, Denmark, Korea, Republic of, New Zealand, Canada, Russian Federation, Poland, Singapore, Hong Kong
-
AlexionCompletedWilson DiseaseUnited States
-
AlexionCompletedWilson DiseaseUnited States